methoxytryptophol has been researched along with luzindole in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barrett, P; Conway, S; Delagrange, P; Drew, JE; Morgan, PJ; Mowat, ES | 1 |
del Mar Arriero, M; Monjo, M; Ramis, JM; Satué, M | 1 |
2 other study(ies) available for methoxytryptophol and luzindole
Article | Year |
---|---|
Serine residues 110 and 114 are required for agonist binding but not antagonist binding to the melatonin MT(1) receptor.
Topics: Acetamides; Amides; Amino Acid Substitution; Animals; Binding Sites; Binding, Competitive; COS Cells; Cyclic AMP; Dose-Response Relationship, Drug; Heterotrimeric GTP-Binding Proteins; Humans; Indoles; Melatonin; Mutagenesis, Site-Directed; Naphthalenes; Protein Binding; Radioligand Assay; Receptors, Cell Surface; Receptors, Cytoplasmic and Nuclear; Receptors, Melatonin; Recombinant Fusion Proteins; Serine; Structure-Activity Relationship; Transfection; Tryptamines | 2001 |
A new role for 5-methoxytryptophol on bone cells function in vitro.
Topics: Animals; Cell Differentiation; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Gene Expression Regulation; In Vitro Techniques; Indoles; MAP Kinase Signaling System; Melatonin; Mice; Osteoblasts; Osteoclasts; RANK Ligand; Tryptamines | 2015 |